Predictive Value of the Systemic Immune-Inflammation Index and CRUSADE Score for Bleeding and Mortality in Older

Ahmet Gürdal1, Ebru Serin1, Mert Sarılar1

  • 1Department of Cardiology, University of Health Sciences, Şişli Hamidiye Etfal Education and Research Hospital, Istanbul, Turkey.

Insights

A high systemic immune-inflammation index (SII) predicts in-hospital bleeding in older acute coronary syndrome (ACS) patients. A high CRUSADE Bleeding Score (CBS) predicts long-term mortality in these patients.

Area of Science:

  • Cardiology
  • Geriatrics
  • Hematology

Background:

  • Limited research exists on the systemic immune-inflammation index (SII) and bleeding risk in elderly acute coronary syndrome (ACS) patients.
  • This study addresses the gap by investigating SII's predictive value for in-hospital bleeding and the CRUSADE Bleeding Score (CBS) for long-term mortality in this demographic.

Purpose of the Study:

  • To evaluate the systemic immune-inflammation index (SII) as a predictor of in-hospital bleeding.
  • To assess the CRUSADE Bleeding Score (CBS) for predicting long-term mortality in elderly patients with ACS.

Main Methods:

  • The study included 367 patients aged 75 and above with ACS.
  • Multivariate logistic regression identified predictors of in-hospital bleeding.
  • Kaplan-Meier analysis assessed survival curves and long-term mortality.

Main Results:

  • High SII was significantly associated with elevated in-hospital bleeding (p=0.005).
  • Estimated glomerular filtration rate (eGFR) and SII were independent predictors of in-hospital bleeding.
  • High CBS (≥46) was linked to significantly increased all-cause mortality (p=0.001).

Conclusions:

  • The systemic immune-inflammation index (SII) independently predicts in-hospital bleeding in older ACS patients.
  • A high CRUSADE Bleeding Score (CBS) upon admission is associated with increased long-term mortality in this patient group.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
38
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
253
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
71